Please use this identifier to cite or link to this item: https://doi.org/10.1158/1535-7163.MCT-06-0240
Title: Methyl-3-indolylacetate inhibits cancer cell invasion by targeting MEK1/2-ERK1/2 signaling pathway
Authors: Zhang, S. 
Huang, Q. 
Shen, H.-M.
Ong, C.-N.
Li, Z.
Wu, X.
Issue Date: 2006
Citation: Zhang, S., Huang, Q., Shen, H.-M., Ong, C.-N., Li, Z., Wu, X. (2006). Methyl-3-indolylacetate inhibits cancer cell invasion by targeting MEK1/2-ERK1/2 signaling pathway. Molecular Cancer Therapeutics 5 (12) : 3285-3293. ScholarBank@NUS Repository. https://doi.org/10.1158/1535-7163.MCT-06-0240
Source Title: Molecular Cancer Therapeutics
URI: http://scholarbank.nus.edu.sg/handle/10635/24458
ISSN: 15357163
DOI: 10.1158/1535-7163.MCT-06-0240
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

20
checked on Jun 14, 2019

WEB OF SCIENCETM
Citations

20
checked on Jun 14, 2019

Page view(s)

197
checked on May 24, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.